BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33865995)

  • 1. Prognostic models in primary central nervous system lymphoma patients: A systematic review.
    Jelicic J; Stauffer Larsen T; Bukumiric Z; Juul-Jensen K; Andjelic B
    Crit Rev Oncol Hematol; 2021 May; 161():103341. PubMed ID: 33865995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
    Li J; Tang X; Luo X; Liu L; Li D; Yang L
    Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
    Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
    Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma.
    Jang JE; Kim YR; Kim SJ; Cho H; Chung H; Lee JY; Park H; Kim Y; Cheong JW; Min YH; Kim JS
    Eur J Cancer; 2016 Apr; 57():127-35. PubMed ID: 26918738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and treatment outcomes in primary central nervous system lymphoma: a descriptive analysis of 62 patients].
    Ge Y; Lin XT; Luo DL; Zhang F; Xu J; Li Z; Liu YH
    Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):861-866. PubMed ID: 31775435
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary central nervous system lymphoma.
    Gerstner ER; Batchelor TT
    Arch Neurol; 2010 Mar; 67(3):291-7. PubMed ID: 20212226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of primary central nervous system lymphoma.
    Ekenel M; DeAngelis LM
    Curr Neurol Neurosci Rep; 2007 May; 7(3):191-9. PubMed ID: 17488584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary central nervous system lymphoma.
    Batchelor TT
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):379-385. PubMed ID: 27913504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary central nervous system lymphoma: essential points in diagnosis and management.
    Paydas S
    Med Oncol; 2017 Apr; 34(4):61. PubMed ID: 28315229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis.
    Shin DW; Kim JH; Kim YH; Cho YH; Hong SH
    J Neurooncol; 2020 Apr; 147(2):339-349. PubMed ID: 32221784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cleveland Clinic experience with primary central nervous system lymphoma.
    Xie H; Ahluwalia MS; Peereboom DM
    Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in primary central nervous system lymphomas.
    Ferreri AJ; Reni M
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):629-49, vi. PubMed ID: 16083827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of primary central nervous system lymphoma.
    Han CH; Batchelor TT
    Cancer; 2017 Nov; 123(22):4314-4324. PubMed ID: 28950405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic markers for immunodeficiency-associated primary central nervous system lymphoma.
    Kaulen LD; Galluzzo D; Hui P; Barbiero F; Karschnia P; Huttner A; Fulbright R; Baehring JM
    J Neurooncol; 2019 Aug; 144(1):107-115. PubMed ID: 31190317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to editor: C‑reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase‑to‑lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single‑center study of 223 patients.
    Un Nisa Mughal Z; Haseeb A
    Neurosurg Rev; 2024 Apr; 47(1):146. PubMed ID: 38600419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
    Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
    Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
    Agarwal PA; Menon S; Smruti BK; Singhal BS
    Neurol India; 2009; 57(6):756-63. PubMed ID: 20139505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.
    Cheatle JT; Aizenberg MR; Weinberg JS; Surdell DL
    World Neurosurg; 2013; 79(3-4):593.e9-13. PubMed ID: 22885166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary CNS Lymphoma.
    Grommes C; DeAngelis LM
    J Clin Oncol; 2017 Jul; 35(21):2410-2418. PubMed ID: 28640701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary central nervous system lymphoma: status and advances in diagnosis, molecular pathogenesis, and treatment.
    Zhang Y; Zhou DB
    Chin Med J (Engl); 2020 Jun; 133(12):1462-1469. PubMed ID: 32452898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.